Abstract
<p style="margin-top:15.4pt; margin-right:0in; margin-bottom:7.7pt; margin-left:0in; text-align:justify">The high prevalence of type 2 diabetes mellitus (T2DM) in Philippines has burdened the health care system. Therefore, we compared standard of care, Insulin30/70+ Insulin Glulisine (Arm B) to a traditional insulin regimen NPH Insulin+Regular Insulin (Arm A) to test the concept that both provide comparable efficacy and safety in real world practice.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
